Use of recombinant activated factor VII in a case of severe postpartum haemorrhage.
We describe the case of a 24 year old woman, affected by haemorrhagic shock due to post-partum uterine atony, who underwent an emergency hysterectomy with persistent postoperative bleeding, successfully treated with recombinant activated factor VII (Novoseven).
Verre
M
M
Department of Anaesthesiology and Intensive Care, S. Giovanni di Dio Hospital, Crotone, Italy. marioverre@tiscali.it
Bossio
F
F
Mammone
A
A
Piccirillo
M
M
Tancioni
F
F
Varano
M
M
D000328:Adult; D015942:Factor VIIa / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D006473:Postpartum Hemorrhage / Q000188:drug therapy*; D011247:Pregnancy; D011994:Recombinant Proteins / Q000627:therapeutic use; D012720:Severity of Illness Index
D011994:Recombinant Proteins; D015942:Factor VIIa